Belpointe Asset Management’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.2M Sell
10,949
-7,207
-40% -$1.03M 0.04% 389
2025
Q4
$3.02M Buy
18,156
+7,537
+71% +$1.26M 0.11% 159
2025
Q3
$2.08M Sell
10,619
-17
-0.2% -$2.79K 0.08% 216
2025
Q2
$962K Buy
+10,636
New +$840K 0.04% 367

Other funds holding ALAB

Belpointe Asset Management's ALAB Position: Q1 2026 in Review

Belpointe Asset Management reduced its Astera Labs (ALAB) stake by 40% in Q1 2026, selling an estimated $1.03M and leaving 10,949 shares worth $1.2M. The position accounts for 0.04% of the portfolio, ranked #389.

Belpointe Asset Management first reported a position in ALAB in Q2 2025 and has held it in 4 quarters since. The position peaked at $3.02M in Q4 2025. 703 funds tracked by Wall St. Rank hold ALAB as of Q1 2026.

  • Belpointe Asset Management held 10,949 shares of Astera Labs worth $1.2M as of Q1 2026.
  • Belpointe Asset Management sold 7,207 Astera Labs shares in Q1 2026, an estimated $1.03M.
  • Astera Labs made up 0.04% of Belpointe Asset Management's portfolio in Q1 2026, its #389 holding.
  • Belpointe Asset Management first reported a position in Astera Labs in Q2 2025 and has held it in 4 quarters since.
  • Belpointe Asset Management's Astera Labs position peaked at $3.02M in Q4 2025.
  • 703 funds tracked by Wall St. Rank held Astera Labs as of Q1 2026.

Based on Belpointe Asset Management's 13F filing for Q1 2026, filed 28 Apr 2026.